Table 2 Classification of responders after 3 weeks and at the end of treatment
From: ImproWin® in the treatment of gastric ulceration of the squamous mucosa in trotting racehorses
Treatment period | a) ImproWin®/ImproWin® (n = 36) | b) Placebo/ImproWin® (n = 11) | c) Placebo/Placebo (n = 31/n = 20) |
|---|---|---|---|
3 weeks | 25/36 | 0/11 | 18/31 |
69.4 (51.9 – 83 .7) | 0.0 (0.0 – 28.5) | 58.1 (40.0 - 74.1) | |
End of treatment | 28/36 | 6/11 | 17/31 |
77.8 (60.9 – 89–9) | 54.6 (23.4 – 83.3) | 54.8 (34.7 – 73.0) |